Under the terms of the agreement, Septerna is eligible to receive around $2.2 billion from Novo Nordisk, including more than $200 million in upfront and near-term milestone payments.

I'm a widow. My husband died suddenly in a car accident about five years ago, so we didn't have time to evaluate our wills. I'm 65. I had my children very young - my first son at 16, the second son at ...

Belgium issued 7 billion euros ($7.83 billion) in a new October 2030-dated government bond via a bank syndicate on Wednesday, one of the lead manager banks said. Books for the new five-year bond ...

Although initially started as a microscope and camera maker 100 years ago, Olympus is now a dedicated medical device company focusing on endoscopic and surgical solutions. We expect Olympus to enjoy ...

Incyte said it agreed to pay Novartis $280 million to settle the disputed royalties on U.S. sales of blood-cancer treatment Jakafi through Dec. 31. The parties also agreed to reduce by 50% the royalty ...